ENANTA PHARMACEUTICA

ENTA
Delayed Quote. Delayed  - 01/22 04:00:00 pm
47.67USD +1.84%

Turn to zoom
Prev.46.8100
Open46.5300
High47.7200
Low46.1100
Volume104 179
Latest news
01/12
01/08
01/08
01/07
Chart ENANTA PHARMACEUTICALS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance48,752,255,3
Spread/Res.-2,1%-8,7%-14%
Spread/Supp.4,5%16%15%
Support45,641,241,4
Financials
Sales 2021 99,2 M - -
Net income 2021 -86,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 -11,5x
Yield 2021 -
Capitalization 960 M 960 M -
Capi. / Sales 2021 9,68x
Capi. / Sales 2022 10,5x
Nbr of Employees 141
Free-Float 88,2%
Company
Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company. The Company uses chemistry-driven approach and drug discovery solutions to create small molecule drugs for the treatment of viral infections and liver diseases. Its research and development programs are...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2021-02-10 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus HOLD
Number of Analysts 8
Average target price 61,75 $
Last Close Price 47,67 $
Spread / Highest target 124%
Spread / Average Target 29,5%
Spread / Lowest Target -37,1%